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Abstract
Francisella tularensis is a Gram-negative facultative intracellular pathogen and the causative agent of tularemia. Recently,
genome-wide screens have identified Francisella genes required for virulence in mice. However, the mechanisms by which
most of the corresponding proteins contribute to pathogenesis are still largely unknown. To further elucidate the roles of
these virulence determinants in Francisella pathogenesis, we tested whether each gene was required for replication of the
model pathogen F. novicida within macrophages, an important virulence trait. Fifty-three of the 224 genes tested were
involved in intracellular replication, including many of those within the Francisella pathogenicity island (FPI), validating our
results. Interestingly, over one third of the genes identified are annotated as hypothetical, indicating that F. novicida likely
utilizes novel virulence factors for intracellular replication. To further characterize these virulence determinants, we selected
two hypothetical genes to study in more detail. As predicted by our screen, deletion mutants of FTN_0096 and FTN_1133
were attenuated for replication in macrophages. The mutants displayed differing levels of attenuation in vivo, with the
FTN_1133 mutant being the most attenuated. FTN_1133 has sequence similarity to the organic hydroperoxide resistance
protein Ohr, an enzyme involved in the bacterial response to oxidative stress. We show that FTN_1133 is required for F.
novicida resistance to, and degradation of, organic hydroperoxides as well as resistance to the action of the NADPH oxidase
both in macrophages and mice. Furthermore, we demonstrate that F. holarctica LVS, a strain derived from a highly virulent
human pathogenic species of Francisella, also requires this protein for organic hydroperoxide resistance as well as
replication in macrophages and mice. This study expands our knowledge of Francisella’s largely uncharacterized intracellular
lifecycle and demonstrates that FTN_1133 is an important novel mediator of oxidative stress resistance.
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Introduction
Francisella tularensis is a unique facultative intracellular pathogen
that can cause a potentially lethal disease with an infectious dose as
low as 10 bacteria [1]. A small Gram-negative coccobacillus, F.
tularensis is the causative agent of tularemia, a vector- and water-
borne zoonotic disease resulting in non-specific, flu-like symptoms
that may culminate in pneumonic, glandular, and systemic
infections [1]. When left untreated, pneumonic tularemia can
result in a mortality rate as high as 60% [2]. F. tularensis subspecies
are endemic across the Northern Hemisphere, with the majority of
reported cases of disease in the United States, Europe, Russia, and
Japan [3]. Due to its extreme infectivity, high morbidity and
mortality rates, history of weaponization, and ease of aerosoliza-
tion, dissemination, and genetic manipulation, F. tularensis is
considered a category A potential bioweapon by the Centers for
Disease Control and Prevention (CDC) [4–6].
The virulence mechanisms of F. tularensis subspecies and other
Francisella species are still being characterized, including the role of
the Francisella pathogenicity island (FPI) which is thought to encode
a Type VI secretion system that facilitates the release of virulence
proteins into host cells [7–13]. While F. tularensis and F. holarctica
are responsible for the majority of disease burden in humans [5],
many important virulence determinants are conserved among
other Francisella species, including F. novicida. In addition to the
FPI, these conserved virulence determinants include the presence
of a non-inflammatory lipopolysaccharide (LPS), protective
capsule, siderophores, and proteins involved in resistance to
oxidative stress [14–21]. F. novicida, which has 98% nucleotide
identity with the human pathogenic species, causes disease mainly
in immunocompromised individuals but has also been shown to
cause disease in healthy individuals [22–24]. The live vaccine
strain (LVS) is an attenuated strain of the highly pathogenic
species F. holarctica that was originally developed as a vaccine and
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work involving F. tularensis and F. holarctica is restricted to Select
Agent Biosafety Level 3 (BSL3) laboratories, both F. novicida and
LVS are approved for use in BSL2 laboratories, are readily
genetically manipulated, and cause tularemia-like disease in mice,
making them both good laboratory models for studying Francisella
pathogenesis [27,28].
Francisella’s primary replicative niche is thought to be the
cytosolic compartment of both phagocytic and non-phagocytic cells
such as macrophages, neutrophils, hepatocytes, alveolar epithelial
cells, and fibroblasts [29–32]. After being engulfed by phagocytic
host cells, the bacteria are taken up into phagosomes where they are
confronted with a myriad of antimicrobial defenses including
degradative enzymes, acidic pH, and oxidative stress [17–21,33–
36]. The reactive oxygen species (ROS) which cause oxidative stress
can directly damage bacterial macromolecules such as proteins,
DNA, and lipids. They can also react with these macromolecules to
generate more ROS and toxic oxygen compounds, including the
highly toxic organic hydroperoxides that result from the destructive
lipid peroxidation of cell membranes [37–40]. Within host cells,
ROS are generated by multiple mechanisms including the NADPH
oxidase, myeloperoxidase, lipoxygenases, and cellular respiration
[41,42]. The NADPH oxidase, which produces superoxide radicals
that lead to ROS formation, has been shown to be important for the
host response to infection with Francisella species [43–46]. These
bacteria employ numerous strategies to resist oxidative stress
including limiting the activation of the NADPH oxidase
[35,36,47] and using multiple enzyme systems to detoxify reactive
oxygen compounds [18,32,48,49].
While a general outline of Francisella’s interaction with host cells
is known, the specific mechanisms of cell entry, phagosomal
escape, cytosolic replication, and some of the ways it evades
immune defenses are still unknown. Genome-wide in vivo screens
have identified genes required for the virulence of several
Francisella species but do not shed light on how the majority of
these genes contribute to pathogenesis [50–52]. As replication
within host cells is a major part of Francisella’s infectious cycle, we
set out to determine which of the genes that are known to be
required for virulence in vivo are also required for replication in
host macrophages.
We performed an intracellular replication screen using trans-
poson mutants representing 224 genes that have previously been
shown to be required for virulence in vivo. Fifty-three of
the genes tested were required for replication in macrophages
including many of the FPI genes, validating the screen. We also
identified biotin biosynthetic genes and the fsl/fig siderophore
biosynthetic genes [16,53–55] as well as numerous proteins of
unknown function as being required for replication in macro-
phages. We validated the intracellular and in vivo requirement of
two of these novel genes, FTN_1133 and FTN_0096. We then
further investigated the importance of FTN_1133, which encodes
a protein with sequence similarity to Ohr, a protein involved in
oxidative stress resistance [56–64]. Accordingly, we find that
FTN_1133 is required for resistance to, and degradation of,
organic hydroperoxides. Furthermore, the replication defect of
the FTN_1133 mutant is rescued in macrophages lacking a
functional NADPH oxidase and partially rescued in mice with the
same defect. We further demonstrate that F. holarctica LVS also
requires this protein for organic hydroperoxide resistance and
replication in macrophages and mice. Taken together, these data
highlight the critical role that novel virulence factors play in
Francisella pathogenesis and contribute to the elucidation of the
requirements for this pathogen’s largely uncharacterized intra-
cellular lifecycle.
Materials and Methods
Ethics Statement
All experimental procedures were approved by the Emory
University Institutional Animal Care and Use Committee
(protocol #069-2008Y).
Bacterial strains and growth conditions
Wild-type F. novicida strain U112, a previously described mglA
point mutant, GB2 [65], and the F. holarctica Live Vaccine Strain
(LVS) were generous gifts from Dr. Denise Monack (Stanford
University, Stanford, CA). F. novicida overnight cultures were
grown at 37uC on a rolling drum in tryptic soy broth (TSB; Difco/
BD, Sparks, MD) supplemented with 0.02% L-cysteine (Sigma-
Aldrich, St. Louis, MO) while LVS cultures were grown in
modified Mueller-Hinton broth (mMHB) supplemented with
1 mM CaCl2, 1 mM MgCl2, 0.1% glucose (Sigma-Aldrich), 2%
Isovitalex (Difco/BD), and 0.025% ferric pyrophosphate as
previously described [66]. Growth in minimal medium was
determined using Chamberlain’s chemically defined minimal
medium, prepared as previously described [67]. For the
replication screen, F. novicida was plated for enumeration on
tryptic soy agar (TSA; Difco/BD) and supplemented with 0.01%
L-cysteine. Bacteria from all other F. novicida experiments were
plated on modified Mueller Hinton (mMH) (Difco/BD) plates
supplemented with 0.025% ferric pyrophosphate (Sigma-Aldrich),
0.1% glucose, and 0.01% L-cysteine. LVS was plated on mMH
supplemented additionally with 2% Isovitalex. When appropriate,
kanamycin (Kan; Fisher Scientific, Fair Lawn, NJ) was added to
media at a concentration of 30 mg/ml for F. novicida and 10 mg/ml
for LVS.
Macrophages
RAW264.7 murine macrophages (ATCC, Manassas, VA) were
cultured in Dulbecco’s modified Eagle medium (high glucose, L-
glutamine; DMEM; Lonza, Walkersville, MD) supplemented with
10% heat-inactivated fetal calf serum (FCS; HyClone, Logan,
UT). Bone marrow-derived macrophages (BMM) were isolated
from either wild-type C57BL/6 or gp91
phox-/- mice (Jackson
Laboratories, Bar Harbor, ME) and cultured as described
previously [68] in DMEM supplemented with 10% heat-
inactivated FCS and 10% macrophage colony-stimulating factor
(M-CSF)-conditioned medium (collected from M-CSF-producing
L929 cells). Macrophages were incubated before and during
infection at 37uC with 5% CO2.
Intracellular replication screen and macrophage
infections
The screen library was assembled by inoculation of individual
transposon mutants from the F. novicida two-allele transposon
library [69] into 96-well plates containing cysteine-supplemented
TSB. These were grown overnight at 37uC, glycerol (Fisher
Scientific) was added to 20% final volume, and the plates were
stored at 280uC. RAW264.7 murine macrophages were seeded at
10
5 cells/well in 96-well tissue culture plates for the replication
screen or 5610
5cells/well in 24-well tissue culture plates for
subsequent infections and incubated overnight. The medium was
then removed and the macrophages were infected with overnight
cultures of individual mutants from the screen library that had
been diluted in DMEM/10% FCS to achieve a multiplicity of
infection (MOI) of twenty bacteria per macrophage. The plates
were centrifuged for 15 minutes at 931 x g at room temperature
and then incubated for 30 minutes. Next, the macrophages were
washed twice with DMEM and incubated for an additional 30
Francisella Macrophage Replication Screen
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cin (TekNova, Hollister, CA). The macrophages were again
washed twice and DMEM/10% FCS with 10 mg/ml gentamicin
was added. At 1 and 24 hours post-infection, the macrophages
were washed twice and then lysed with 1% saponin (Alfa Aesar,
Heysham, Lancs., UK) in phosphate buffered solution (PBS)
without calcium and magnesium (Lonza, Walkersville, MD). Serial
dilutions of the resulting macrophage lysates were plated onto
cysteine-supplemented TSA in sterile 24-well plates. Finally, the
colony forming units (CFU) for each transposon mutant were
counted and the fold replication (CFU at 24 hr/ CFU at 1 hr) was
calculated and compared to the fold replication of wild-type F.
novicida U112. A similar infection procedure was followed for both
wild-type and gp91
phox-/- BMM infections with the following
modifications: 3610
5 BMM were plated per well in a 24-well
plate, DMEM/10% FCS/10% M-CSF was used throughout and
the final time point was 5.5 hours for F. novicida infections or 24
hours for LVS infections. The replication screen was performed
twice and the data were averaged to determine the final results. All
transposon mutants that replicated less than or equal to 30% of the
wild-type value (mutant fold replication/wild-type fold replication
#0.3) were considered attenuated for replication in vitro. Results
for all transposon mutants tested are listed in Table S1.
Mutagenesis and complementation
To generate F. novicida deletion mutants, PCR was used to
amplify flanking DNA regions upstream and downstream of the
gene of interest. A Kan-resistance cassette was sewn in between
these flanking regions using overlapping PCR reactions. The final
linear PCR products were then gel purified and transformed into
chemically competent wild-type U112 as previously described
[70]. The primers used to create the Kan-resistant deletion
mutants contained FRT sites flanking the Kan-resistance cassette,
which allowed removal of the cassette using the plasmid pFFlp
encoding the Flp-recombinase as previously described [71].
Constructs for the complementation of each mutant were
generated by overlapping PCR using PCR-amplified fragments
of the wild-type gene of interest, upstream and downstream
flanking regions, and a Kan-resistance cassette. These constructs
were then transformed into the appropriate chemically competent
deletion mutants. Verification of allelic replacement in mutant and
complemented strains was performed using check primers in PCR
reactions on purified genomic DNA from each strain. PCR
products of the correct size were subsequently sequenced (MWG
Operon, Huntsville, AL) for final verification of allelic replace-
ment. For LVS mutagenesis, we employed both targeted gene
disruption via group II introns as previously described [72] and
allelic replacement. Briefly, in order to perform targeted gene
disruption, primers for targeting the FTL_0803 allele were
generated using the TargeTron system (Sigma-Aldrich) and the
resulting PCR product was cloned into the Francisella targeting
vector, pKEK1140 (generously provided by Dr. Karl Klose,
UTSA, San Antonio, TX) [72]. LVS was then transformed with
the resulting vector and FTL_0803 insertion mutants were selected
for as previously described [72]. To generate LVS deletion
mutants via allelic replacement, PCR was used to amplify flanking
DNA regions upstream and downstream of the gene of interest
which were then sewn together using overlapping PCR reactions.
The final linear PCR products were then gel purified, digested
with BamHI restriction enzyme (New England Biolabs, Ipswich,
MA), dephosphorylated with Antarctic phosphatase (New England
Biolabs), and ligated using T4 ligase (New England Biolabs) into
the Francisella suicide vector pXB186 that encodes the sacB enzyme
(James Bina, University of Tennessee, Memphis, TN). LVS was
then transformed and mutants selected as previously described
[73,74]. Briefly, pXB186 ligations were transformed into LVS via
electroporation and plated on chocolate agar with kanamycin
(10 ug/ml). Next, kanamycin resistant colonies were plated on
10% sucrose, 1% hemoglobin cysteine heart agar (CHA) and
surviving colonies were then patched onto kanamycin plates.
Finally, genomic DNA from the kanamycin sensitive colonies
was PCR-verified and sequenced to confirm the deletion. The
FTL_0803 targeted disruption mutant was used in the RAW264.7
LVS macrophage experiment and the FTL_0803 clean deletion
mutant was used in all other LVS experiments. Neither FTN_1133
nor FTL_0803 appear to be in an operon as the genes adjacent to
both are transcribed in opposing directions. All primers used in
this study are listed in Table S2.
Mouse experiments
Female C57BL/6 and gp91
phox-/- mice (Jackson Laboratory,
Bar Harbor, ME) between 7 and 10 weeks of age were kept under
specific pathogen-free conditions in filter-top cages at Emory
University and provided with sterile food and water ad libitum.
Experimental studies were performed in accordance with the
Emory University Institutional Animal Care and Use Committee
guidelines. For competition experiments, mice were inoculated
subcutaneously with a 1:1 ratio of kanamycin-resistant deletion
mutant and kanamycin-sensitive wild-type F. novicida for a total of
2610
5 CFU in 50 ml sterile PBS. For single infections, mice were
infected with 2610
5 CFU subcutaneously. After 48 (F. novicida
infections) or 72 hours (LVS infections), mice were sacrificed and
the spleen, liver, and skin at the site of infection were harvested,
homogenized (Tissue Tearor, Cole-Parmer, Vernon Hills, Illinois),
plated for CFU on MH plates (with and without kanamycin for
competition experiments), and then incubated overnight at 37uC.
For single infections, organs were weighed before homogenization
and the resulting CFU were divided by the weight of each organ to
determine CFU/gram. For survival experiments, mice were
infected as described for single strain infections and then observed
for illness and sacrificed if they appeared moribund. For collection
of RNA, mice were infected intraperitoneally with an infectious
dose of 2610
6 CFU, four hours after which the mice were
sacrificed and the livers collected for RNA isolation. Competitive
index (CI) values were determined using the formula: (CFU
mutant output/CFU WT output)/(CFU mutant input/CFU WT
input).
RNA isolation and quantitative real-time PCR
At various time points post-infection, BMM were lysed and
homogenized in trizol reagent (MRC, Cincinnati, Ohio). Similar-
ly, liver samples from intraperitoneally-infected mice (4 hours post-
infection) were homogenized in trizol reagent. For both in vitro and
in vivo samples, RNA was isolated using the RNeasy Mini kit
(QIAGEN, Germantown, MD). Gene-specific primers (Table S2)
were used to amplify FTN_1133 transcripts using the Power Sybr
Green One Step Kit (Applied Biosystems, Foster City, CA) on an
Applied Biosystems StepOnePlus Real Time PCR System per the
manufacturers’ instructions. Expression of FTN_1133 transcript
was calculated relative to the expression of the DNA helicase uvrD
(FTN_1594).
Susceptibility assays
Overnight cultures of F. novicida or LVS strains were diluted to
an OD600 of 1.0 and 100 ml of each were spread on mMH agar
plates. Six mm filter disks (Bel-Art Scienceware, Lake Charles, LA)
were then added to the center of each plate and 3 ml of the
appropriate dilution of chemical agent was spotted on the disks.
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250 mM (F. novicida) and 25 mM (LVS) tert-butyl hydroperoxide,
150 mM cumene hydroperoxide, 3% H2O2, and 200 mg/ml
sodium dodecyl sulfate (SDS). Plates were then grown overnight at
37uC and the zones of inhibition measured.
Organic hydroperoxide degradation assay
Degradation of tert-butyl hydroperoxide was measured using a
xylenol orange colorimetric assay based on previously described
methods [59,60,75,76]. Briefly, overnight cultures of F. novicida
were subcultured to an OD600 of 0.01–0.03 and then incubated
with shaking at 37uC. Once cultures reached mid-log phase
(,OD600 1.0), they were diluted to OD600 0.5 and a 2 ml sample
of each culture or TSB alone were added to a 24 well plate. Tert-
butyl hydroperoxide was then added to each sample to a final
concentration of 300 mM, after which the plate was incubated with
shaking at room temperature for 30 minutes. 20 ml samples were
taken every five minutes from each well and immediately added to
80 ml2 5m MH 2SO4. Once all samples were collected, 100 ml
reaction buffer [200 mM xylenol orange (Alfa Aesar), 200 mM
ammonium ferrous sulfate (Ricca Chemical, Arlington, TX), and
25 mM H2SO4 (Fisher Scientific) prepared in 9:1 methanol to
water solution] was added to each well and the OD540 measured.
The concentration of tert-butyl hydroperoxide in each sample was
calculated based on a standard curve.
Statistical analysis
All macrophage replication, susceptibility, and qRT-PCR data
were analyzed for significance using the unpaired Student’s t test.
The CI values from the mouse experiments were analyzed with
the one-sample Student’s t test and compared to 1, with the
exception of the CI values comparing replication in wild-type
versus gp91
phox-/- mice which were analyzed using the unpaired
Student’s t test. The single strain mouse infection data were
analyzed for significance using the Mann-Whitney test.
Results
Intracellular replication screen
To further characterize the role in virulence of genes known to
be required in animal infection models, we screened a library of
corresponding transposon mutants for replication in RAW264.7
macrophages. We screened a total of 451 transposon mutants
representing 224 genes and identified 53 of these genes to be
required for F. novicida replication in RAW264.7 macrophages
(Table 1). The screen results were validated by the identification of
genes that have previously been reported to be required for
intracellular replication, including genes encoded in the Francisella
Pathogenicity Island (FPI) [8,9,11,12,77–80]. To the best of our
knowledge, this study is the first to report the requirement of
Francisella’s biotin biosynthetic genes and the fsl/fig siderophore
biosynthetic genes for replication in mammalian cells [16,53–55].
A more in-depth review of the genes identified in this screen is
included in the Discussion. Interestingly, a large proportion of the
genes identified to be required for intracellular replication by this
screen encode proteins of unknown function. Two such proteins
were chosen for further study: FTN_0096 and FTN_1133.
FTN_0096 was selected because of the severe intracellular
replication defect of the FTN_0096 transposon mutant (Table 1).
FTN_1133 was chosen because, although it is annotated as a
hypothetical protein, we found that it has sequence similarity to
Ohr, a protein involved in resistance to organic hydroperoxides
which can induce oxidative stress, resistance to which is a critical
virulence mechanism of Francisella species [17–21,56–63].
Validation of Screen Results
Deletion mutants for FTN_0096 and FTN_1133 were generated
using allelic replacement as previously described [70]. The
mutants exhibited wild-type replication kinetics when grown in
both tryptic soy broth (TSB) supplemented with cysteine (Fig. S1A)
and Chamberlain’s chemically defined minimal medium (Fig.
S1B). To validate the phenotypes of the corresponding transposon
mutants in our screen, the replication phenotype of each deletion
mutant was determined in RAW264.7 macrophages. Twenty-four
hours post-infection, the FTN_0096 mutant was severely attenu-
ated for replication compared to wild-type F. novicida, with a fold
replication value similar to that of the replication-deficient control
strain, GB2, which we will refer to as mglA (Fig. 1A). This strain
harbors a point mutation in mglA, a gene known to be essential for
intracellular replication [65]. The FTN_1133 mutant displayed an
approximate six-fold replication deficiency compared to wild-type
(Fig. 1C). In order to ensure that the observed phenotypes resulted
from deletion of the targeted gene and not unintended secondary
site mutations, we generated complemented strains of each mutant
in which the deleted gene was replaced. All of the complemented
strains displayed wild-type levels of replication (Fig. 1A, C). These
data further validate our screen and demonstrate the requirement
of FTN_0096 and FTN_1133 for F. novicida replication in
RAW264.7 macrophages.
To verify that the replication defects of these F. novicida mutants
were not specific to RAW264.7 cells, we next infected primary
murine bone marrow-derived macrophages (BMM) and measured
replication levels. Compared to the wild-type strain, the
FTN_0096 mutant again displayed a severe replication deficiency
similar to the mglA mutant, and the FTN_1133 mutant had an
approximate three-fold replication defect (Fig. 1B, D). Replication
was restored to the wild-type level in the complemented strains
(Fig. 1B, D). We measured bacterial replication at 5.5 hrs post-
infection, before any macrophage cell death occurred, to ensure
that the attenuated phenotypes of the mutants were not a
consequence of the cell death response. RAW264.7 macrophages
are known to be deficient in ASC/caspase-1 inflammasome-
mediated cell death [81], an inflammatory host cell death pathway
known to be triggered by F. novicida infection [82], explaining why
we could measure bacterial replication at later time points in these
cells. Taken together, these results demonstrate that in both of the
macrophage cell types tested, FTN_0096 and FTN_1133 play a
role in replication and that the deletion mutants lacking these
genes displayed intracellular replication deficiencies similar to
those predicted by our screen.
Deletion mutants are attenuated in vivo
To test whether the macrophage replication defects correlated
with in vivo attenuation levels, competition experiments were
performed in mice. Briefly, mice were infected with a 1:1 ratio of
wild-type F. novicida and each mutant strain. Forty-eight hours
post-infection, mouse organs were harvested, homogenized, and
plated for enumeration of wild-type and mutant CFU. The
number of FTN_0096 deletion mutant CFU in the spleen and liver
was one log below that of wild-type (Fig. 2B, C), although no
attenuation was observed in the skin (Fig. 2A). The FTN_1133
mutant had a one log attenuation in the skin, roughly two log
attenuation in the spleen, and nearly three log attenuation in the
liver (Fig. 2). Both mutant phenotypes were restored to wild-type
levels in the complemented strains (Fig. 2). Taken together, these
results demonstrate that FTN_0096 and FTN_1133 are involved
in F. novicida pathogenesis in vivo, though FTN_1133 appears to
have a more significant role in virulence in mice.
Francisella Macrophage Replication Screen
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F. novicida
locus
F. tularensis
locus Gene name
Gene
description
Mammalian in
vivo attenuation
references
Mammalian in
vitro attenuation
references
FTN_0019 FTT1665 pyrB aspartate carbamoyltransferase [50] [29,32,78,89]
FTN_0020 FTT1664 carB Carbamoyl-phosphate synthase large chain [50,112] [29,32,78,89]
FTN_0021 FTT1663 carA Carbamoyl-phosphate synthase small chain [50] [29,32,78]
FTN_0035 FTT1648c pyrF Orotidine 59-phosphate decarboxylase [50] [78]
FTN_0036 FTT1647c pyrD diyroorotate dehydrogenase [50] [78]
FTN_0096 FTT1689c NA conserved hypothetical membrane protein [50][ 78]
FTN_0109 FTT1676 NA hypothetical protein [51,108] [78,89,108]
FTN_0177 FTT0203c purH bifunctional purine biosynthesis protein [50,112] [29]
FTN_0178 FTT0204 purA adenylosuccinate synthetase [112,113] [29,113]
FTN_0419 FTT0893 purM Phosphoribosylaminoimidazol (AIR) synthetase [50,112]
FTN_0422 FTT0896 purE phosphoribosylaminoimidazole carboxylase,catalyic
subunit
[50] [114]
FTN_0430 FTT0904 lpnB conserved hypothetical lipoprotein [50,52]
FTN_0544 FTT0453c NA conserved hypothetical protein [50]
FTN_0546 FTT0455c flmK dolichyl-phosphate-mannose-protein
mannosyltransferase family protein
[50,115]
FTN_0593 FTT0503c sucD succinyl-CoA synthetase, alpha subunit [51] [89,114]
FTN_0594 FTT0504c sucC succinyl-CoA synthetase subunit beta [51,112] [114]
FTN_0599 FTT0509c NA conserved hypothetical protein [50]
FTN_0812 FTT0934c bioD dethiobiotin synthetase [51]
FTN_0813 FTT0935c bioC biotin synthesis protein BioC [51]
FTN_0814 FTT0936c bioF 8-amino-7-oxononanoate synthase [50,51]
FTN_0815 FTT0937c bioB biotin synthase [50]
FTN_0816 FTT0938 bioA Adenosylmethionine-8-amino-7-oxononanoate
aminotransferase
[50]
FTN_0818 FTT0941c NA lipase/esterase [50,51]
FTN_0848 FTT0968c NA amino acid antiporter [50,51] [78]
FTN_1133 FTT1152 NA protein of unknown function [51,52]
FTN_1240 FTT1221 NA hypothetical protein [51] [78]
FTN_1254 FTT1236 NA hypothetical protein [50] [29,114]
FTN_1310 FTT1700; FTT1345 pdpB/icmF conserved hypothetical protein [50,79,112] [78,79]
FTN_1311 FTT1701; FTT1346 iglE conserved hypothetical protein [50] [78]
FTN_1312 FTT1702; FTT1347 vgrG conserved hypothetical protein [9,50,52] [9,78]
FTN_1313 FTT1703; FTT1348 iglF conserved hypothetical protein [50] [78]
FTN_1314 FTT1704; FTT1349 iglG conserved hypothetical protein [50] [78]
FTN_1315 FTT1705; FTT1350 iglH conserved hypothetical protein [50] [78]
FTN_1316 FTT1706; FTT1351 dotU conserved hypothetical protein [50] [78]
FTN_1317 FTT1707; FTT1352 iglI conserved hypothetical protein [9,50] [9,78]
FTN_1318 FTT1708; FTT1353 iglJ conserved hypothetical protein [50,79] [78,79]
FTN_1321 FTT1711c; FTT1356c iglD intracellular growth locus, subunit D [50,52] [12,78,80]
FTN_1322 FTT1712c; FTT1357c iglC intracellular growth locus, subunit C [8,50,51,116] [8,12,77,78,116]
FTN_1323 FTT1713c; FTT1358c iglB intracellular growth locus, subunit B [50,51,117] [12,78,117]
FTN_1324 FTT1714c; FTT1359c iglA intracellular growth locus, subunit A [50,51] [11,12,78]
FTN_1421 FTT1456c wbtH asparagine synthase [50] [89,114]
FTN_1423 FTT1457c wbtG glycosyl transferase [50]
FTN_1427 FTT1461c wbtD galacturonosyl transferase [50]
FTN_1501 FTT1490 NA Na+/H+ antiporter [50] [29,91]
FTN_1586 FTT0129 NA major facilitator superfamily sugar transporter [29]
FTN_1608 FTT0107c dsbB disulfide bond formation protein [29,50,91,112] [29,78,91]
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locus
F. tularensis
locus Gene name
Gene
description
Mammalian in
vivo attenuation
references
Mammalian in
vitro attenuation
references
FTN_1682 FTT0029c figA/ fslA conserved siderophore protein [50,51]
FTN_1683 FTT0028c figB/ fslB conserved siderophore protein [50]
FTN_1684 FTT0027c figC/fslC diaminopimelate decarboxylase siderophore
protein
[50]
FTN_1699 FTT1720c purL phosphoribosylformylglycinamidine synthase [50,106,112] [91]
FTN_1700 FTT1721c purF amidophosphoribosyltransferase [50,106,113] [91,113]
FTN_1715 FTT1736c kdpD two component sensor protein kdpD [50,118]
FTN_1743 FTT1769c clpB ClpB protein [50,51,92,119] [12,78,91,92]
Strains highlighted in bold were chosen for further characterization in this study.
doi:10.1371/journal.pone.0024201.t001
Table 1. Cont.
Figure 1. Validation of replication screen results. RAW264.7 macrophages (A and C) or primary murine bone marrow-derived macrophages
(BMM) (B and D) were infected with a 20:1 MOI of the indicated bacterial strains. Twenty-four (A and C) or 5.5 (B and D) hours post-infection, fold
replication was determined for the FTN_0096 (A and B) and FTN_1133 (C and D) deletion mutants (D96 and D1133) and their respective
complemented strains. Wild-type F. novicida and an mglA point mutant strain (GB2) were used as positive and negative replication controls,
respectively. For each strain, bars represent the average fold replication and error bars represent the standard deviation (n=3). Data shown is
representative of at least three independent experiments. Asterisks indicate significance as compared to wild-type. (**) p,0.005, (***) p,0.0005.
doi:10.1371/journal.pone.0024201.g001
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Since the FTN_1133 mutant was the most severely attenuated in
vivo, we chose this gene for further characterization. To ensure that
the attenuation of this mutant was not only observed when in
competition with wild-type bacteria, we performed single infection
experiments. We observed that the FTN_1133 mutant was
attenuated in each organ to a similar degree as in competition
experiments (Fig. 3A–C), confirming that FTN_1133 is required
for full virulence of F. novicida. We further verified this result by
monitoring the survival of these mice. By day 10 post-infection,
only 40% of mice infected with wild-type bacteria survived while
100% of those infected with the FTN_1133 deletion mutant
survived (Fig. 3D).
FTN_1133 is expressed during infection of macrophages
and mice
Given its importance in F. novicida replication and survival in
macrophages and mice, we tested whether FTN_1133 was
transcribed during infection. Levels of FTN_1133 transcript from
samples of wild-type F. novicida-infected BMM at 30 minutes, 2
hours, and 4 hours post-infection were determined using
quantitative real-time RT-PCR (qRT-PCR) (Fig. 4A). The
expression of FTN_1133 was induced during macrophage
infection, as indicated by a moderate but significant increase in
expression between 30 minutes and 4 hours (Fig. 4A). We also
observed a similar level of expression in livers of infected mice 4
hours after intraperitoneal infection (Fig. 4B). Taken together and
consistent with its role in pathogenesis, these results show that
FTN_1133 is expressed during infection of both macrophages and
mice.
FTN_1133 is involved in resistance to organic
hydroperoxides
Bioinformatic analysis revealed that FTN_1133 has sequence
similarity to an organic hydroperoxide resistance protein (Ohr)
from Bacillus megaterium. Specifically, the C-terminal half of Ohr
has significant similarity to residues 18–86 of FTN_1133 (Fig. S2).
Based on these findings, we tested whether FTN_1133 is involved
in resistance to organic hydroperoxides in F. novicida.W e
quantified bacterial sensitivity by measuring zones of inhibition
upon exposure to organic hydroperoxides via the disk diffusion
method. The FTN_1133 mutant showed increased sensitivity to
cumene and tert-butyl hydroperoxides compared to the wild-type
and complemented strains (Fig. 5A, B). Since Ohr is often required
for resistance to organic hydroperoxides but not inorganic
hydroperoxides [59,60,62,63,83], we grew the bacterial strains in
Figure 2. FTN_0096 and FTN_1133 deletion mutants are attenuated for virulence in vivo. Mice were subcutaneously infected with a 1:1
mixture of wild-type F. novicida and either D96 or D1133 (10
5 CFU each) or respective complemented strains. Forty-eight hours after infection, organs
were harvested, CFU enumerated, and the competitive index (CI) calculated for the skin at the site of infection (A), spleen (B), and liver (C). CI = (CFU
mutant output/CFU WT output)/(CFU mutant input/CFU WT input). Bars represent the geometric mean CI values from each group of mice (n=5). CI
values below 1 (dashed line) indicate attenuation of the mutant strain. Data shown is representative of two independent experiments. Asterisks
indicate significance as compared to a CI value of 1. (***) p,0.0005.
doi:10.1371/journal.pone.0024201.g002
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5 CFU of
either wild-type F. novicida (WT) or the FTN_1133 mutant (D1133). Forty-eight hours after infection, organs were harvested and plated and CFU were
enumerated 24 hours later for the skin at the site of infection (A), spleen (B), and liver (C). To test survival, mice were infected as described above and
then sacrificed upon display of moribundity (D). Bars represent the geometric mean of each group of mice (n=5). Data shown is representative of
two independent experiments. Asterisks indicate significance. (**) p,0.005, (*) = P,0.05.
doi:10.1371/journal.pone.0024201.g003
Figure 4. FTN_1133 is expressed during infection of macrophages and mice. Relative expression of FTN_1133 was determined in wild-type F.
novicida-infected BMM (A) at 30 minutes, 1 hour, and 4 hours post-infection with an MOI of 20:1 and (B) in the livers of intraperitoneally-infected mice
at 4 hours. Relative expression of FTN_1133 transcript was calculated by comparison with the expression levels of the DNA helicase uvrD (FTN_1594).
Data shown is representative of two independent experiments. Bars represent the standard deviation from each set of samples (n=5). Asterisk
indicates significance compared to 30 minutes. (*) p,0.05.
doi:10.1371/journal.pone.0024201.g004
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wild-type, mutant, and complemented strains showed equal levels
of sensitivity, indicating that FTN_1133 is indeed not required for
resistance to an inorganic hydroperoxide (Fig. 5C). Finally, to
further demonstrate the specificity of FTN_1133 for organic
hydroperoxides and rule out a general sensitivity to stresses, we
found that the wild-type, mutant and complemented strains were
equally susceptible to SDS, a membrane-damaging detergent
(Fig. 5D). Taken together, these data demonstrate that FTN_1133,
similar to most Ohr proteins, is required for resistance to organic
but not inorganic hydroperoxides.
FTN_1133 is required for degradation of an organic
hydroperoxide
To determine if FTN_1133 is important not only for resistance
to organic hydroperoxides, but also detoxification of these
chemicals, we added tert-butyl hydroperoxide to cultures of
wild-type F. novicida or the FTN_1133 deletion mutant and
measured its concentration over time. Between 15 minutes and 30
minutes, the FTN_1133 deletion mutant degraded approximately
50% less tert-butyl hydroperoxide than wild-type bacteria (Fig. 6).
These data indicate that FTN_1133 is involved in degradation of
an organic hydroperoxide.
FTN_1133 is required for resistance to the action of the
NADPH oxidase
To test if the sensitivity of the FTN_1133 mutant to oxidative
stress was the cause of its replication defect in macrophages, we
infected BMM from both wild-type and gp91
phox-/- mice with
wild-type F. novicida and the FTN_1133 deletion mutant. gp91 is a
subunit of the NADPH oxidase and is required for the generation
of reactive oxygen species and the oxidative stress induced by this
enzyme. While the FTN_1133 mutant was attenuated for
replication in wild-type BMM (Fig. 7A, and similar to Fig. 1), it
replicated to the same levels as wild-type F. novicida in the
gp91
phox-/- BMM (Fig. 7B). In order to determine whether a
similar phenotype is observed in vivo, we infected wild-type and
gp91
phox-/- mice with either wild-type F. novicida or the FTN_1133
deletion mutant. Indeed, the two log attenuation of the FTN_1133
deletion mutant in wild-type mice was rescued by one log in
gp91
phox-/- mice (Fig. 7C). Together, these data indicate that
FTN_1133 is required to resist the oxidative stress generated by
Figure 5. FTN_1133 confers resistance to organic hydroperoxides. Two hundred and fifty mM tert-butyl hydroperoxide (A), 150 mM cumene
hydroperoxide (B), 3% hydrogen peroxide (C), and 200 mg/ml SDS (D) were spotted on filter disks placed on lawns of wild-type, FTN_1133 mutant
(D1133), and the complemented strain and the zones of inhibition for each were measured. In each graph, bars represent the mean and error bars
represent the standard deviation (n=3). Data shown is representative of at least three independent experiments. Asterisks indicate significance as
compared to wild-type. (***) p,0.0005.
doi:10.1371/journal.pone.0024201.g005
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novicida’s intracellular and in vivo pathogenesis.
The FTN_1133 ortholog, FTL_0803, confers resistance to
an organic hydroperoxide
In order to determine whether FTN_1133 is also involved in
organic hydroperoxide resistance in other Francisella species, we
constructed an F. holarctica LVS deletion mutant lacking the
FTN_1133 ortholog, FTL_0803. FTN_1133 and FTL_0803 share
98% amino acid identity. To test the requirement of FTL_0803
for LVS resistance to organic hydroperoxides, we performed disk
diffusion assays on wild-type LVS and the FTL_0803 deletion
mutant. As with FTN_1133, we found that FTL_0803 is required
for wild-type resistance to the organic hydroperoxide tert-butyl
hydroperoxide (Fig. 8A), but not H2O2 (Fig. 8B) or SDS (Fig. 8C).
FTL_0803 is required for F. holarctica LVS virulence and
resistance to the action of the NADPH oxidase
Next we investigated the importance of FTL_0803 in LVS
pathogenesis by determining the replication phenotype of the
deletion mutant both in macrophages and mice. First, RAW264.7
macrophages were infected with wild-type LVS and the FTL_0803
mutant, and bacterial levels were measured at 24 hours post-
infection. Similar to the phenotype of the FTN_1133 mutant, the
Figure 7. FTN_1133 is required for resistance to the action of the NADPH oxidase. Wild-type (A) or gp91
phox-/- (B) bone marrow-derived
macrophages were infected with a 20:1 MOI of the indicated bacterial strains. (A, B) Five and a half hours post-infection, fold replication (CFU at
5.5 hr/ CFU at 30 minutes) was determined for wild-type F. novicida and the FTN_1133 deletion mutant (D1133). For each strain, bars represent the
average fold replication and error bars represent the standard deviation (n=3). Data shown are representative of three independent experiments. (C)
Wild-type and gp91
phox-/- mice were subcutaneously infected with a 1:1 mixture of wild-type F. novicida and D1133 (10
5 CFU each). Forty-eight hours
after infection, organs were harvested, CFU enumerated, and the competitive index (CI) calculated. Data shown include two independent
experiments. Asterisks indicate significance as compared to wild-type F. novicida. (*) p,0.05, (***) p,0.0005.
doi:10.1371/journal.pone.0024201.g007
Figure 6. FTN_1133 is required for degradation of an organic
hydroperoxide. Three hundred mM tert-butyl hydroperoxide was
added to cultures of wild-type F. novicida (circles), the FTN_1133
deletion mutant (D1133, squares), or TSB media alone (triangles) and its
degradation was measured over time. Data points represent the mean
and error bars represent the standard deviation (n=3). Data shown is
representative of at least three independent experiments.
doi:10.1371/journal.pone.0024201.g006
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defect (Fig. 9A). Mouse infection experiments revealed that the
FTL_0803 deletion mutant was present at one log lower levels
than LVS in the organs tested (Fig. 9B–D). Finally, to determine if
the replication deficiency of this mutant in macrophages is also
rescued in the absence of a functional NADPH oxidase, we
infected both wild-type BMM and gp91
phox-/- BMM with either
LVS or the FTL_0803 deletion mutant. The five-fold replication
deficiency of the mutant in wild-type BMM was largely rescued in
gp91
phox-/- BMM (Fig. 10). These data demonstrate that the
importance of FTN_1133/FTL_0803 in resisting oxidative stress,
promoting intracellular replication, and contributing to in vivo
virulence is conserved in multiple Francisella species.
Discussion
Recently, in vivo screens have identified many genes required for
Francisella virulence, though the functions of these genes and an
understanding of the stage of infection at which they contribute to
virulence are largely unknown [50,51]. In an effort to further
characterize these virulence determinants and to begin to answer
questions that remain regarding Francisella’s intracellular lifecycle,
we performed an intracellular replication screen using transposon
insertion mutants of genes that were identified in the two
mammalian in vivo genome-wide screens that were published at
the time of this study: one using F. novicida transposon mutants [50]
and one using transposon mutants of the Francisella live vaccine
strain (LVS) [51]. Recently, Kraemer et al. published another
mammalian in vivo genome-wide screen, the results of which were
published after our screen was performed and therefore genes
specifically identified in this study were not included [52].
Of the 224 genes screened, 53 were shown to be required for
replication in murine macrophages. The 171 genes that were not
identified in this screen may be required for replication in other
cell types known to be infected by Francisella, such as neutrophils,
hepatocytes, alveolar epithelial cells, or fibroblasts [29–32,84,85].
Alternatively, these genes may be required for processes other than
intracellular replication such as immune evasion or systemic
dissemination. To the best of our knowledge, the intracellular
replication data from mutants for 140 of the 224 genes that were
represented in this screen have not been previously reported in
mammalian cells. One gene, feoB (FTN_0066), was included in the
screen but was excluded from the results because of a growth
defect on cysteine-enriched tryptic soy agar (TSA), despite no
apparent growth defect in cysteine-enriched tryptic soy broth
(TSB) (data not shown).
The results of our screen were validated by the identification of
genes that have previously been shown to be required for
replication in macrophages, including most of the Francisella
pathogenicity island (FPI) genes [8,9,11,12,77–80,86]. Of the 18
genes in the F. novicida FPI, mutants representing 13 genes were
identified as attenuated for replication in macrophages. Among
the FPI genes not identified in this screen (pdpA, pdpC, pdpD, pdpE,
and anmK), pdpD has previously been reported to be unnecessary
for replication in mouse macrophages [87]. Both pdpC and pdpD
were also shown to be unnecessary for replication in an arthropod
Figure 8. The FTN_1133 ortholog, FTL_0803, confers resistance to tert-butyl hydroperoxide. Twenty-five mM tert-butyl hydroperoxide (A),
3% hydrogen peroxide (B), and 200 mg/ml SDS (C) were spotted on filter disks placed on lawns of wild-type LVS or the FTL_0803 mutant (D803),
incubated overnight, and then the zones of inhibition for each were measured. In each experiment, bars represent the mean and error bars represent
the standard deviation (n=3). Data shown is representative of at least three independent experiments. Asterisks indicate significance as compared to
wild-type. (**) p,0.005.
doi:10.1371/journal.pone.0024201.g008
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have no role in virulence in a live arthropod model [78]. While
pdpA has been shown to be required for intracellular replication
within mammalian cells [10,78,86], it was not identified in this
screen. One of the three pdpA transposon mutants we tested
displayed a deficiency in intracellular replication, but it was just
below the cut-off value used in this screen (Table S1). This may be
due to retention of some protein function in the pdpA mutant
strains used in this study, a potential problem when using
transposon mutants as compared to deletion mutants.
In addition to the identification of FPI genes, this screen was
further validated by the identification of other genes that have
previously been shown to be required for intracellular replication,
including pyrB [29,32,78], carA [29,32,78], carB [29,32,78,89],
purM [90] and clpB [12,78,91,92]. Genes that have previously been
shown to play no role in intracellular replication and were also
shown to be unnecessary for replication in our screen include
FTN_0757 and FTN_0720, verifying the selectivity of our screen
[50]. Though an htpG deletion mutant has previously been
reported to be attenuated for replication in BMM macrophages
[50], and one of the two transposon mutants with insertions in this
gene displayed an approximate two-fold replication attenuation in
this screen, the level of attenuation was not sufficient for our cut-
off.
Our screen led to numerous novel insights into Francisella’s
genetic requirements for replication within host cells. To the best
Figure 9. FTL_0803 is important for LVS replication in macrophages and mice. (A) RAW264.7 macrophages were infected with a 20:1 MOI of
wild-typeLVSandtheFTL_0803mutant(D803).Twenty-fourhourspost-infection, intracellularCFUs were determined forbothstrains. Barsrepresentthe
mean and error bars represent the standard deviation (n=3). (B–D) Mice were subcutaneously infected with 2610
5 CFU of either wild-type F. holarctica
LVS (WT) or the FTL_0803 mutant (D803). Seventy-two hours after infection, organs were harvested, plated, and CFU were enumerated 48 hours later for
the skin at the site of infection (B), spleen (C), and liver (D). Bars represent the geometric mean from each group of mice (n=5). Data shown is
representative of two independent experiments. Asterisks indicate significance as compared to wild-type. (*) p,0.05, (**) p,0.005.
doi:10.1371/journal.pone.0024201.g009
Figure 10. FTL_0803 contributes to resistance against the
action of the NADPH oxidase. Bone marrow-derived macrophages
(BMM) were infected with a 20:1 MOI of wild-type LVS or the FTL_0803
mutant (D803). Twenty-four hours post-infection, fold replication was
determined for both strains. Bars represent the mean and error bars
represent the standard deviation (n=3). Data shown is representative
of two independent experiments. Asterisks indicate significance as
compared to wild-type. (**) p,0.005.
doi:10.1371/journal.pone.0024201.g010
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of biotin for Francisella’s replication in mammalian cells since each
of the biotin synthetic genes, bioA, bioB, bioC, bioD, and bioF
(FTN_0812-FTN_0816) was identified. Biotin is critical for various
metabolic pathways and biotin biosynthetic genes are required for
Mycobacterium tuberculosis intracellular replication and pathogenesis
[93–95]. bioF was also recently reported to be important for
Francisella replication in an arthropod cell line [96]. In addition,
we report here for the first time Francisella’s requirement for
replication in mammalian cells of at least three of the six
siderophore biosynthetic genes: fslA, fslB, and fslC, also known as
figA, figB, and figC (FTN_1682-FTN_1684), confirming that this
iron acquisition system is essential for efficient replication within
mammalian cells. Pathogens generally encounter iron-limiting
conditions within the host, and thus iron acquisition proteins are
critical virulence factors in numerous pathogens [97,98]. fslA and
fslB were also recently reported to be important for replication in
an arthropod cell line [96]. The other three genes from this group
(FTN_1685-FTN_1687) were not included in our screen.
Of the 53 genes identified to be required for replication in this
screen, 19 are annotated as hypothetical, indicating that F. novicida
encodes novel genes that are required both for virulence in vivo and
intracellular replication. To study the role of some of these
hypothetical proteins during infection as well as further validate
the screen results, we chose two genes to study: FTN_0096 and
FTN_1133. FTN_0096 is a member of the DUF1275 superfamily
of proteins, which has members in other human pathogens such as
Vibrio spp, Acinetobacter spp, Neisseria spp, and Burkholderia spp.
Analysis with the Simple Modular Architecture Research Tool
(SMART) identified 7 potential transmembrane domains as well as
a putative signal peptide, indicating that FTN_0096 is likely a
membrane protein (http://smart.embl-heidelberg.de/). Interest-
ingly, bioinformatic analyses revealed that FTN_1133 was found
only in Francisella species but had significant similarity to the C-
terminal domain of an organic hydroperoxide resistance protein,
Ohr, from Bacillus megaterium.
We show that both FTN_0096 and FTN_1133 are required for
replication in macrophages and virulence in mice. FTN_0096 was
absolutely required for replication in both RAW264.7 macro-
phages and BMM (Fig. 1A, B). In addition, FTN_0096 was
recently reported to be important for replication in an arthropod in
vivo model as well as murine macrophage-like J774 cells [78]. The
FTN_0096 deletion mutant displayed only a moderate one log
attenuation in the spleen and liver of mice, despite having a severe
intracellular replication defect (Fig. 2). The disparity in this
mutant’s in vivo versus in vitro phenotypes could be due to an ability
of bacteria lacking FTN_0096 to replicate efficiently in other cells
types, particularly non-immune cells that have fewer defenses
against intracellular infection. Indeed, Horzempa et al. recently
showed that a uracil synthesis mutant unable to replicate in
macrophages displayed a virulent phenotype in mice attributable
to that mutant’s ability to replicate in non-phagocytic host cells
[99]. Conversely, the FTN_1133 mutant was moderately attenu-
ated for intracellular replication (3-6 fold) in macrophages (Fig. 1),
displayed a marked two to three log attenuation in the spleen and
liver following mouse infections (Fig. 2, 3), and did not cause lethal
infection in mice (Fig. 3D). Furthermore, we showed that
FTN_1133 was expressed during infection of both macrophages
and mice (Fig. 4).
Bioinformatic analyses revealed that FTN_1133, a 127 amino
acid protein, has significant similarity to the C-terminal domain of
an organic hydroperoxide resistance protein (Ohr) from Bacillus
megaterium (Fig. S2). The C-terminus of Ohr proteins has been
shown to be important for enzymatic function in bacteria such as
Xylella fastidiosa and Pseudomonas aeruginosa [83,100–102]. Originally
identified in Xanthomonas campestris, Ohr is a 139 amino acid protein
which has homologs in several bacterial species including Bacillus
subtilis, Pseudomonas aeruginosa, and Acinetobacter baumannii
[56,57,59,61]. Ohr is thought to be a hydroperoxide reductase
that converts organic hydroperoxides into less toxic metabolites
[101]. This protein contributes to resistance to reactive oxygen
species (ROS)-induced damage by degrading the highly toxic
organic hydroperoxides that are created during lipid peroxidation
when oxygen radicals react with the unsaturated and polyunsat-
urated lipids of cell membranes [37–40,100].
Interestingly, Ohr proteins are usually only involved in
resistance to organic hydroperoxides, such as tert-butyl hydroper-
oxide and cumene hydroperoxide, but not inorganic hydroperox-
ides, such as hydrogen peroxide [59,60,62,63,83]. Our disk
diffusion analysis indicates that FTN_1133, like many Ohr
proteins, is required for resistance to organic hydroperoxides but
not hydrogen peroxide (Fig. 5). Also similar to Ohr, we
demonstrate that FTN_1133 is required for degradation of tert-
butyl hydroperoxide (Fig. 6) [59,60,75,76]. The FTN_1133
deletion mutant displays a moderate amount of degradation
compared to the wild-type strain, which indicates that Francisella
may encode another system involved in degradation of these
chemicals. Potential candidates for this function include Franci-
sella’s uncharacterized AhpC homologs. Most proteins involved in
oxidative stress resistance specifically detoxify inorganic oxygen
species, such as oxide radicals (superoxide dismutases) or hydrogen
peroxide (catalase). However, AhpC has been shown to be
important for resistance to both inorganic and organic hydroper-
oxides in other bacterial pathogens such as P. aeruginosa, Brucella
abortus, and Salmonella typhimurium [103–105]. Consistent with a role
in virulence, Kadzhaev et al. demonstrated that an F. tularensis
ahpC transposon mutant showed a marked increase in time to
death in a low dose challenge in mice [106].
While expression of ohr genes is often increased in response to
organic hydroperoxides, several ohr genes have been identified that
are not induced in this manner [57,62,64]. Quantitative real-time
PCR analysis of FTN_1133 expression revealed that while the
gene is induced during infection (Fig. 4), this gene was not
significantly induced in broth in our hands in response to organic
hydroperoxides (data not shown).
To the best of our knowledge, ohr mutants have not previously
been characterized in host cells or animal models, though ohr has
been shown to be co-expressed with other virulence factors during
Actinobacillus pleuropneumoniae infection of pigs [60]. Further
suggestive of a role in pathogenesis, ohr is sometimes encoded on
mobile genetic elements, such as a genomic island in Actinobacillus
pleuropneumoniae [107] and a plasmid in pathogenic Acinetobacter
baumannii [61]. Our in vitro screen and previous in vivo screens
[51,52] identified FTN_1133 as important for virulence. We
hypothesized that increased sensitivity of the FTN_1133 mutant to
oxidative stress may explain its intracellular and in vivo replication
defect. Indeed, we observed restoration of wild-type levels of
intracellular replication for the FTN_1133 deletion mutant in
BMM from mice lacking gp91
phox-/- (Fig. 7B), an essential subunit
of NADPH oxidase that is required for the generation of
superoxide radicals by this enzyme complex. In addition, the in
vivo attenuation of the FTN_1133 mutant was significantly rescued
in gp91
phox-/- mice (Fig. 7C). Though the mutant was not fully
complemented in these mice as it was in the gp91
phox-/- BMM, this
is not surprising since there are alternate ROS generating
pathways that do not exist in macrophages but are present during
in vivo infection. For example, myeloperoxidase is present in
neutrophils but not macrophages and can initiate lipid peroxidation
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demonstrate that the importance of FTN_1133 in resistance to
oxidative stress is conserved in multiple Francisella species by
showing the requirement of FTL_0803,t h eF. holarctica LVS
FTN_1133ortholog,forresistancetoorganichydroperoxides(Fig.8)
and wild-type replication both in macrophages and mice ( Fig. 9).
Finally, we show that the in vitro attenuation of the FTL_0803
mutant was largely rescued in macrophages deficient in oxidative
burst (Fig. 10). The molecular bases for the attenuation of the LVS
strain have yet to be fully characterized and as such, there may be
underlying deficiencies that explain the incomplete complementa-
tion of the FTL_0803 mutant strain in gp91
phox-/- BMM [26].
Our data demonstrating a role for FTN_1133 in resistance to
oxidative stress and Francisella virulence are consistent with the fact
that many oxidative stress resistance genes are transcribed during
Francisella infection of macrophages [108] and many of these have
been identified in screens as being required for replication in
macrophages [78,89] and virulence in arthropods [20,78,96].
Francisella species have been shown to use an array of genes to
suppress activation of the NADPH oxidase [32,35,36,45,109].
Francisella species also use numerous genes to detoxify reactive
oxygen compounds and thereby resist oxidative stress. Specifically,
the catalase KatG [48,49,51,89] and the superoxide dismutases
SodB and SodC [18,49,110] have all been shown to be essential
for survival of Francisella species in vivo. Also, a novel oxidative stress
resistance gene, MoxR, was recently described in LVS [21]. The
data presented here identify FTN_1133 as a novel Francisella
oxidative stress resistance protein, specific for stress induced by
organic hydroperoxides.
In this report, we demonstrate for the first time the importance
of an Ohr-like protein in virulence during in vitro and in vivo
infections as well as its specific role in resistance to oxidative stress
both in macrophages and in mice. Furthermore, we show that the
importance of this protein for pathogenesis is conserved in
multiple Francisella species. Taken together, the results of this
screen highlight the requirement of numerous F. novicida virulence
determinants for intracellular replication. The critical importance
of resisting oxidative stress suggests that Ohr-like proteins,
including FTN_1133, may represent attractive drug targets
[111]. In this way, continued characterization of FTN_1133 and
other novel proteins and mechanisms used by Francisella could
contribute to the development of new therapeutics and vaccines
against this potential bio-threat.
Supporting Information
Figure S1 Selected deletion mutants of genes identified
in the replication screen display wild-type growth in rich
media and in defined minimal media. Bacterial growth at
37uC in (A) cysteine-enriched tryptic soy broth and (B)
Chamberlain’s minimal defined media is shown for wild-type F.
novicida (circles), FTN_0096 (D96, squares), and FTN_1133 (D1133
triangles). Data shown is representative of at least three
independent experiments.
(TIF)
Figure S2 FTN_1133 has similarity to the organic
hydroperoxide resistance protein Ohr. The sequences for
F. novicida FTN_1133 (a.a. 18 – 86) and Bacillus megaterium Ohr (a.a.
71 – 139) were aligned using CLUSTALW (http://www.ebi.ac.
uk/Tools/msa/clustalw2/). Identical residues are highlighted in
red and similar residues are highlighted in blue. The sequences
have 28.6% identity and 42.9% similarity.
(TIF)
Table S1 Full list of transposon mutant replication
phenotypes in RAW264.7 macrophages. Strains highlighted
in bold were attenuated for intracellular replication. Each
transposon mutant was screened 2–3 times and each time the
fold replication of the mutant was compared to the fold replication
of wild-type (fold Mut/ fold WT). AVG Mut/WT is the average of
these ratios from all experiments for each mutant. Strain names,
plate number, and well location are as annotated in the two-allele
transposon mutant library from Gallagher, et al.
(DOC)
Table S2 Primers used in this study.
(DOC)
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